Cisplatin is the preferred chemotherapy drug for lung adenocarcinoma, but the specific treatment plan still needs to be determined by combining the condition and type. Lung adenocarcinoma belongs to one type of lung cancer, and there are many chemotherapy drugs, clinically, the third generation of cisplatin-based chemotherapy drugs is the main one, but generally the effect of single-drug chemotherapy is not ideal, and it needs to be combined with other drugs for joint treatment, such as pemetrexed plus cisplatin, or pemetrexed plus carboplatin. Each patient’s condition, drug sensitivity and other different, need to be combined with the specific situation to determine, can also be used docetaxel, vincristine, gemcitabine, paclitaxel and other chemotherapeutic drugs treatment. During the use of drugs, patients may experience vomiting, headache and other adverse reactions, is a normal phenomenon, without special treatment, such as the situation is relatively serious to consult a doctor in a timely manner, under the guidance of the doctor active treatment.